Medicines Optimisation Innovation Centre, Antrim, Northern Ireland.
Department of Health, Belfast, Northern Ireland.
Int J Clin Pharm. 2024 Oct;46(5):1001-1009. doi: 10.1007/s11096-024-01775-1. Epub 2024 Jul 23.
Sub-optimal medicines use is a challenge globally, contributing to poorer health outcomes, inefficiencies and waste. The Medicines Optimisation Innovation Centre (MOIC) was established in Northern Ireland by the Department of Health (DH) in 2015 to support implementation of the Medicines Optimisation Quality Framework.
To demonstrate how MOIC informs policy and provides support to commissioners to improve population health and wellbeing.
MOIC is a regional centre with multidisciplinary and multi-sector clinical expertise across Health and Social Care and patient representation.
Core funded by DH, MOIC has a robust governance structure and oversight programme board. An annual business plan is agreed with DH. Rigorous processes have been developed for project adoption and working collaboratively with industry.
MOIC has established partnerships with academia, industry, healthcare and representative organisations across Europe, participating in research and development projects and testing integrated technology solutions. A hosting programme has been established and evaluation and dissemination strategies have been developed.
MOIC has established numerous agreements, partnered in three large EU projects and strengthened networks globally with extensive publications and conference presentations. Informing pathway redesign, sustainability and COVID response, MOIC has also assisted in the development of clinical pharmacy services and antimicrobial stewardship in Europe and Africa. Northern Ireland has been recognised as a 4-star European Active and Healthy Ageing Reference Site and the Integrated Medicines Management model as an example of best practice in Central and Eastern Europe.
MOIC has demonstrated considerable success and sustainability and is applicable to health systems globally.
全球范围内存在药物使用不当的问题，这导致了更差的健康结果、效率低下和浪费。药品优化创新中心（MOIC）于 2015 年由北爱尔兰卫生部（DH）成立，旨在支持药品优化质量框架的实施。
展示 MOIC 如何为政策提供信息，并为决策者提供支持，以改善人口健康和福祉。
MOIC 是一个拥有跨卫生和社会保健多学科和多部门临床专业知识以及患者代表的区域中心。
MOIC 由 DH 核心资助，拥有稳健的治理结构和监督计划委员会。与 DH 达成了年度业务计划。已经为项目采用制定了严格的流程，并与行业合作。
MOIC 已与欧洲各地的学术界、工业界、医疗保健和代表性组织建立了合作伙伴关系，参与研发项目并测试集成技术解决方案。已经建立了托管计划，并制定了评估和传播策略。
MOIC 已经达成了众多协议，与三个大型欧盟项目合作，并在全球范围内加强了网络，广泛发表文章和会议演讲。MOIC 为途径重新设计、可持续性和 COVID 应对提供了信息支持，还协助在欧洲和非洲发展临床药学服务和抗菌药物管理。北爱尔兰被公认为 4 星级欧洲积极健康老龄化参考地点，综合药物管理模式被认为是中东欧最佳实践的范例。
MOIC 已经取得了相当大的成功和可持续性，并适用于全球的卫生系统。
